ATPW
LGND icon

Ashton Thomas Private Wealth’s Ligand Pharmaceuticals LGND Stock Holding History

Ashton Thomas Private Wealth’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$539K Sell
1,704
-490
-22% -$115K 0.01% 757
2026
Q1 		$438K Buy
2,194
+91
+4% +$18K 0.01% 765
2025
Q4 		$398K Buy
2,103
+89
+4% +$17.1K 0.01% 732
2025
Q3 		$357K Buy
2,014
+56
+3% +$8.32K 0.01% 731
2025
Q2 		$223K Sell
1,958
-25
-1% -$2.67K 0.01% 776
2025
Q1 		$208K Buy
1,983
+36
+2% +$4.07K 0.01% 767
2024
Q4 		$209K Buy
+1,947
New +$220K 0.01% 741
2024
Q3 		– Sell
-1,891
Closed -$159K – 1295
2024
Q2 		$159K Buy
+1,891
New +$150K 0.01% 632

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ashton Thomas Private Wealth's LGND Position: Q2 2026 in Review

Ashton Thomas Private Wealth reduced its Ligand Pharmaceuticals (LGND) stake by 22% in Q2 2026, selling an estimated $115K and leaving 1,704 shares worth $539K. The position accounts for 0.01% of the portfolio, ranked #757.

Ashton Thomas Private Wealth first reported a position in LGND in Q2 2024 and has held it in 8 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Ashton Thomas Private Wealth held 1,704 shares of Ligand Pharmaceuticals worth $539K as of Q2 2026.
  • Ashton Thomas Private Wealth sold 490 Ligand Pharmaceuticals shares in Q2 2026, an estimated $115K.
  • Ligand Pharmaceuticals made up 0.01% of Ashton Thomas Private Wealth's portfolio in Q2 2026, its #757 holding.
  • Ashton Thomas Private Wealth first reported a position in Ligand Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.